STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Clinical trials for STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sarcoma: drug combo aims to slow tumor growth
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcoma that has spread. The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from multiplying. The goal is to see if this combination is safer and works better than the current s…
Matched conditions: STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:32 UTC
-
Immunotherapy boost may slow rare sarcomas
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy (doxorubicin) helps people with advanced or spreading sarcomas live longer without their cancer getting worse. About 365 adults with specific sarcoma types will be randomly assi…
Matched conditions: STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC